Kimball Electronics, Inc. KE
Kimball Electronics was founded in 1961 and incorporated in 1998. We deliver a package of value that includes durable, high-reliability electronics, higher level and final assemblies, and contract development and manufacturing organization ("CDMO") solutions. Through our Kimball Solutions platform, we provide integrated manufacturing solutions that combine electronics manufacturing services, medical disposables, drug delivery solutions, precision molded plastics, and end-to-end product lifecycle support. Our CDMO solutions support the production of medical disposables and drug delivery devices, from precision molded plastics and cold chain management to drug integration. The acquisition of Helvoet Polymer Technologies B.V. ("Helvoet") on July 1, 2026, which occurred after our fiscal year end and is therefore reported as a subsequent event in Note 22 - Subsequent Event of Notes to Consolidated Financial Statements, expanded our capabilities in precision molded plastics, complex tooling, and medical device component manufacturing, enhancing our ability to provide comprehensive solutions to customers across the medical and pharmaceutical markets. Customers and industry trade publications regularly award us for our design, engineering, and manufacturing expertise that, coupled with robust processes and procedures, help us ensure that we deliver the highest levels of quality, reliability, and innovative service throughout the entire life cycle of our customers' products. Our Customer Relationship Management ("CRM") model is key to providing our customers convenient access to our highly integrated global footprint, enabled by our largely standardized operating system and procedures.
Valuation FY2026 figures against the last close
Where the revenue comes from as reported in the latest 10-K
Revenue by geography
- Mexico
- United States
- Poland
- China
- Thailand
- Other Foreign
| Region | FY2026 | FY2025 | FY2024 |
|---|---|---|---|
| Mexico | $359.7M | $445.7M | $519.3M |
| United States | $293.6M | $341.8M | $405.0M |
| Poland | $288.7M | $241.9M | $261.4M |
| China | $236.5M | $258.9M | $248.1M |
| Thailand | $158.6M | $132.3M | $171.3M |
| Other Foreign | $94.3M | $66.1M | $109.4M |
As the company reported it, from the “Note 18. Geographic Information - Segments, Geographic Areas (Details)” note of its latest 10-K. Every figure here has been checked against the total revenue the same filing reported. Regions are the filer's own and are not mapped onto a standard list — one company's “Americas” and another's “United States” are different areas, and making them look comparable would mean making at least one of them wrong. Slices under 1% are folded into “Other”.
Annual financial statements
Income statement
| Fiscal year | FY2026 | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $1.43B | $1.49B | $1.71B | $1.82B | $1.35B | $1.29B | $1.20B | $1.18B | $1.07B | $930.9M |
| Cost of revenue | $1.31B | $1.38B | $1.57B | $1.67B | $1.24B | $1.17B | $1.12B | $1.09B | $986.0M | $855.5M |
| Gross profit | $117.5M | $104.4M | $140.3M | $156.2M | $104.6M | $118.0M | $83.8M | $88.4M | $86.0M | $75.4M |
| SG&A | $61.2M | $50.3M | $66.6M | $68.6M | $53.4M | $52.7M | $43.9M | $46.7M | $44.0M | $36.7M |
| Operating income | $66.1M | $45.5M | $49.3M | $87.7M | $52.5M | $65.7M | $32.0M | $42.1M | $42.0M | $42.8M |
| Interest expense | $8.5M | $14.7M | $22.8M | $16.3M | $2.7M | $2.2M | $4.4M | $4.1M | $527.0K | $271.0K |
| Pre-tax income | $53.2M | $26.2M | $25.2M | $74.7M | $43.7M | $70.1M | $25.2M | $38.5M | $44.8M | $44.3M |
| Income tax | $25.3M | $9.2M | $4.7M | $18.9M | $12.5M | $13.3M | $7.0M | $6.9M | $28.0M | $10.1M |
| Net income | $28.0M | $17.0M | $20.5M | $55.8M | $31.3M | $56.8M | $18.2M | $31.6M | $16.8M | $34.2M |
| EPS, basic | 1.14 | 0.68 | 0.82 | 2.24 | 1.24 | 2.26 | 0.72 | 1.22 | 0.63 | 1.25 |
| EPS, diluted | 1.13 | 0.68 | 0.81 | 2.22 | 1.24 | 2.24 | 0.71 | 1.21 | 0.62 | 1.24 |
| Shares, diluted (wtd. avg.) | 24.8M | 25.0M | 25.3M | 25.1M | 25.2M | 25.3M | 25.4M | 26.1M | 27.0M | 27.5M |
Balance sheet
| Fiscal year | FY2026 | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash and equivalents | $88.9M | $88.8M | $78.0M | $43.9M | $49.9M | $106.4M | $65.0M | $49.3M | $46.4M | $44.6M |
| Receivables | $218.8M | $222.6M | $282.3M | $308.2M | $222.9M | $203.4M | $180.1M | $225.6M | $173.6M | $169.8M |
| Inventory | $271.9M | $273.5M | $338.1M | $450.3M | $395.6M | $200.4M | $219.0M | $203.8M | $201.6M | $144.6M |
| Total current assets | $693.0M | $699.6M | $847.0M | $929.4M | $761.1M | $583.4M | $558.4M | $555.3M | $437.0M | $388.2M |
| Property, plant and equipment | $274.2M | $264.8M | $269.7M | $267.7M | $206.8M | $163.3M | $154.5M | $143.6M | $137.2M | $137.5M |
| Goodwill | $6.2M | $6.2M | $6.2M | $12.0M | $12.0M | $12.0M | $12.0M | $18.1M | $6.2M | $6.2M |
| Other intangibles | $1.9M | $2.4M | $3.0M | $12.3M | $14.7M | $17.0M | $19.3M | $22.2M | $4.4M | $4.6M |
| Total assets | $1.09B | $1.08B | $1.21B | $1.26B | $1.04B | $814.1M | $774.8M | $764.1M | $608.8M | $554.9M |
| Accounts payable | $234.4M | $218.8M | $213.6M | $322.3M | $300.2M | $216.5M | $203.7M | $197.0M | $187.8M | $154.6M |
| Total current liabilities | $332.1M | $318.6M | $375.3M | $475.1M | $408.7M | $300.8M | $272.6M | $274.9M | $228.6M | $199.2M |
| Long-term debt | $116.2M | $147.1M | $294.8M | — | — | — | — | — | — | — |
| Total liabilities | — | — | — | — | — | — | — | — | — | $212.7M |
| Retained earnings | $361.5M | $333.5M | $316.6M | $296.1M | $240.2M | $209.0M | $152.2M | $134.0M | $99.4M | $82.7M |
| Total equity | $585.1M | $569.9M | $540.5M | $524.0M | $454.0M | $442.0M | $379.4M | $369.9M | $355.5M | $342.3M |
Cash flow
| Fiscal year | FY2026 | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating cash flow | $72.3M | $183.9M | $73.2M | -$13.8M | -$83.2M | $130.1M | $72.8M | -$6.7M | $40.2M | $46.8M |
| Depreciation and amortisation | $38.7M | $37.0M | $38.0M | $32.4M | $29.4M | $34.0M | $30.9M | $28.9M | $26.4M | $23.9M |
| Stock-based compensation | $8.2M | $6.5M | $7.2M | $6.9M | $6.2M | $3.9M | $4.0M | $5.7M | $5.3M | $3.5M |
| Capital expenditure | $51.5M | $33.3M | $46.1M | $89.4M | $74.0M | $38.4M | $38.4M | $24.7M | $25.9M | $33.3M |
| Investing cash flow | -$25.9M | -$14.7M | -$46.5M | -$90.5M | -$74.8M | -$38.8M | -$38.5M | -$68.7M | -$26.2M | -$35.7M |
| Financing cash flow | -$47.0M | -$160.9M | $9.0M | $99.2M | $103.7M | -$53.1M | -$17.9M | $79.4M | -$12.6M | -$22.0M |
| Buybacks | $11.9M | $12.0M | $2.8M | $0 | $9.0M | $3.0M | $8.8M | $23.4M | $9.6M | $22.3M |
Figures as tagged in each year's own filing, in US dollars. A year restated by a later filing shows the restated figure. Capital expenditure, dividends and buybacks are cash out, shown positive. A line the filer does not report is not listed. Latest from accession 0001606757-26-000032.
Plot the figures US dollars
- Revenue
- Gross profit
- Net income
| Fiscal year | FY2017 | FY2018 | FY2019 | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 | FY2026 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $930.9M | $1.07B | $1.18B | $1.20B | $1.29B | $1.35B | $1.82B | $1.71B | $1.49B | $1.43B |
| Gross profit | $75.4M | $86.0M | $88.4M | $83.8M | $118.0M | $104.6M | $156.2M | $140.3M | $104.4M | $117.5M |
| Net income | $34.2M | $16.8M | $31.6M | $18.2M | $56.8M | $31.3M | $55.8M | $20.5M | $17.0M | $28.0M |
Recent filings and events
- Annual report filed A new 10-K. The figures and the business description on this site come from it. Form 10-K
- Results announced The quarterly or annual earnings release. Arrives four times a year from almost every company here. Item 2.02
- Material agreement signed The company entered an agreement outside the ordinary course of business - a large contract, a credit facility, a merger agreement. Item 1.01
- Regulation FD disclosure Something the company told the market and had to tell everyone at once - usually a slide deck or a press release. Item 7.01
- Results announced Item 2.02
- Other event The catch-all. The company chose to disclose something that fits no other item, so the content is whatever it says it is. Item 8.01
- Results announced Item 2.02
- Other event Item 8.01
- Shareholder vote The results of the annual meeting or a special vote. Item 5.07
- Other event Item 8.01
- Results announced Item 2.02
- Annual report filed Form 10-K
Item numbers are Form 8-K's own, and a filing date is up to four business days after the thing it reports. The same feed across the whole market.
Others in SIC 3672
| Ticker | Company | Market cap | P/E | Revenue growth |
|---|---|---|---|---|
| CLS | CELESTICA INC | $29.90B | 36.3x | 28.5% |
| JBL | JABIL INC | $28.71B | 46.3x | 3.2% |
| FLEX | FLEX LTD. | $28.28B | 32.9x | 8.1% |
| TTMI | TTM TECHNOLOGIES INC | $8.44B | 47.7x | 19.0% |
| SANM | SANMINA CORP | $8.35B | 34.9x | 7.4% |
| PLXS | PLEXUS CORP | $5.78B | 34.7x | 1.8% |
| BHE | BENCHMARK ELECTRONICS INC | $2.36B | 96.8x | -0.4% |
| CTS | CTS CORP | $1.52B | 24.2x | 5.2% |